MRNA
Price
$24.25
Change
-$0.13 (-0.53%)
Updated
May 9 closing price
Capitalization
9.38B
81 days until earnings call
VIR
Price
$5.08
Change
-$0.32 (-5.91%)
Updated
May 9 closing price
Capitalization
702.05M
81 days until earnings call
Ad is loading...

MRNA vs VIR

Header iconMRNA vs VIR Comparison
Open Charts MRNA vs VIRBanner chart's image
Moderna
Price$24.25
Change-$0.13 (-0.53%)
Volume$7.13M
Capitalization9.38B
Vir Biotechnology
Price$5.08
Change-$0.32 (-5.91%)
Volume$1.22M
Capitalization702.05M
MRNA vs VIR Comparison Chart
Loading...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRNA vs. VIR commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNA is a StrongBuy and VIR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (MRNA: $24.25 vs. VIR: $5.09)
Brand notoriety: MRNA: Notable vs. VIR: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNA: 73% vs. VIR: 97%
Market capitalization -- MRNA: $9.38B vs. VIR: $702.05M
MRNA [@Biotechnology] is valued at $9.38B. VIR’s [@Biotechnology] market capitalization is $702.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNA’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • MRNA’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than MRNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNA’s TA Score shows that 3 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • MRNA’s TA Score: 3 bullish, 4 bearish.
  • VIR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both MRNA and VIR are a bad buy in the short-term.

Price Growth

MRNA (@Biotechnology) experienced а -12.17% price change this week, while VIR (@Biotechnology) price change was -17.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

MRNA is expected to report earnings on Jul 31, 2025.

VIR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($9.38B) has a higher market cap than VIR($702M). VIR YTD gains are higher at: -30.722 vs. MRNA (-41.679). VIR has higher annual earnings (EBITDA): -537.61M vs. MRNA (-3.39B). MRNA has more cash in the bank: 7.03B vs. VIR (905M). VIR has less debt than MRNA: VIR (97.9M) vs MRNA (747M). MRNA has higher revenues than VIR: MRNA (3.2B) vs VIR (63.7M).
MRNAVIRMRNA / VIR
Capitalization9.38B702M1,336%
EBITDA-3.39B-537.61M631%
Gain YTD-41.679-30.722136%
P/E RatioN/AN/A-
Revenue3.2B63.7M5,022%
Total Cash7.03B905M776%
Total Debt747M97.9M763%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRNAVIR
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWJ72.010.18
+0.25%
iShares MSCI Japan ETF
SUSB24.890.03
+0.12%
iShares ESG 1-5 Year USD Corp Bd ETF
CSF51.03N/A
N/A
VictoryShares US Discovery Enhanced Volatility Wtd ETF
KJAN35.91N/A
N/A
Innovator US Small Cap Pwr Buff ETF™ Jan
IWLG45.36-0.07
-0.15%
NYLI Winslow Large Cap Growth ETF

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-6.01%
SANA - VIR
62%
Loosely correlated
+0.55%
AXON - VIR
47%
Loosely correlated
-0.33%
CPRX - VIR
43%
Loosely correlated
+2.68%
GOSS - VIR
41%
Loosely correlated
-0.89%
IMNM - VIR
40%
Loosely correlated
-3.24%
More